Article

Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritis

2014-01-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 066b0035-0652-5a88-8e68-f850a0d63b67
DOI: 10.1186/1546-0096-12-s1-p26
PMCID: PMC4184211

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genetic determinants of methotrexate treatment efficacy in patients with juvenile idiopathic arthritisDOI 10.1186/1546-0096-12-s1-p26Read

In the Pursuit of Methotrexate Treatment Response Biomarker in Juvenile Idiopathic Arthritis-Are We Getting Closer to Personalised Medicine?Semantic proximity Read

The genetics of juvenile idiopathic arthritis: current understanding and future prospects.Semantic proximity Read

Magnitude of the genetic component in juvenile idiopathic arthritisSemantic proximity Read

The genetics of juvenile rheumatoid arthritis.Semantic proximity Read

Testing pharmacogenetic indices to predict efficacy and toxicity of methotrexate monotherapy in a rheumatoid arthritis patient cohort.Semantic proximity Read

Juvenile idiopathic arthritis genetics - what's new? What's next?Semantic proximity Read

Genome-wide data reveal novel genes for methotrexate response in a large cohort of juvenile idiopathic arthritis cases.Semantic proximity Read

Genetic and Genomic Markers of Anti-TNF Treatment Response in Rheumatoid ArthritisSemantic proximity Read

Genetic background of juvenile idiopathic arthritis.Semantic proximity Read

Genome-wide association study of response to methotrexate in early rheumatoid arthritis patientsSemantic proximity Read

Genetic analysis of juvenile rheumatoid arthritis: approaches to complex traits.Semantic proximity Read

Pharmacogenomics in childhood rheumatic disorders: a foundation for future individualized therapy.Semantic proximity Read